RESILIENCE

Resilience provides end-to-end biopharmaceutical manufacturing and development solutions. The company is dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. It was founded in La Jolla, California in 2020.

#SimilarOrganizations #People #Financial #More

RESILIENCE

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Health Care Life Science Pharmaceutical

Founded:

2020-01-01

Status:

Active

Email Addresses:

[email protected]

Total Funding:

2.03 B USD

Similar Organizations

antengene-corporation-logo

Antengene Corporation

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

arbor-biotechnologies-logo

Arbor Biotechnologies

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

Current Advisors List

george-barrett_image

George Barrett Board Member @ Resilience
Board_member
2020-11-01

not_available_image

Christopher Darby Board Member @ Resilience
Board_member
2020-11-01

not_available_image

Beverly Davidson Advisor @ Resilience
Advisor
2020-11-01

mark-mcclellan_image

Mark McClellan Advisor @ Resilience
Advisor
2020-11-01

not_available_image

Denice Torres Board Member @ Resilience
Board_member
2020-11-01

mitchell-daniels_image

Mitchell Daniels Board Member @ Resilience
Board_member
2020-11-01

kaye-foster_image

Kaye Foster Board Member @ Resilience
Board_member
2020-11-01

sue-desmond-hellmann_image

Sue Desmond-Hellmann Board Member @ Resilience
Board_member
2020-11-01

Current Employees Featured

olivia-zetter_image

Olivia Zetter
Olivia Zetter Head of Government Affairs and AI Strategy @ Resilience
Head of Government Affairs and AI Strategy

georgeta-puscalau_image

Georgeta Puscalau
Georgeta Puscalau Chief Quality Officer @ Resilience
Chief Quality Officer

richard-shea_image

Richard Shea
Richard Shea Senior Director of Software Engineering @ Resilience
Senior Director of Software Engineering
2021-04-01

not_available_image

Syed T. Husain
Syed T. Husain Chief Commercial Officer @ Resilience
Chief Commercial Officer
2021-01-01

sandy-mahatme_image

Sandy Mahatme
Sandy Mahatme President, COO and CFO @ Resilience
President, COO and CFO
2020-01-01

not_available_image

David Dervaux
David Dervaux Directeur industriel @ Resilience
Directeur industriel
2022-03-01

dwight-baker_image

Dwight Baker
Dwight Baker Vice President Of Engineering @ Resilience
Vice President Of Engineering
2021-05-01

eytan-abraham_image

Eytan Abraham
Eytan Abraham VP, Head of Cell Therapy Franchise @ Resilience
VP, Head of Cell Therapy Franchise
2021-09-01

rahul-singhvi_image

Rahul Singhvi
Rahul Singhvi Co-Founder & CEO @ Resilience
Co-Founder & CEO
2020-07-01

tori-arens_image

Tori Arens
Tori Arens Vice President, Site Head, General Manager @ Resilience
Vice President, Site Head, General Manager
2021-10-01

Founder

drew-oetting_image

Drew Oetting

rahul-singhvi_image

Rahul Singhvi

Acquisitions List

Date	Company	Article	Price
2021-12-02	Swiftscale Biologics	Swiftscale Biologics acquired by Resilience	N/A
2021-04-12	Ology Bioservices	Ology Bioservices acquired by Resilience	N/A

Investors List

magnetic-ventures_image

Investments List

Date	Company	Article	Money raised
2021-11-18	Cellevolve Bio	Resilience investment in Seed Round - Cellevolve Bio	6 M USD
2021-11-05	bit.bio	Resilience investment in Series B - bit.bio	103 M USD
2021-09-23	Garuda Therapeutics	Resilience investment in Series A - Garuda Therapeutics	72 M USD